Literature DB >> 36003420

The aortic valve with two leaflets.

Justin T Tretter1, Diane E Spicer2,3, Jeffrey P Jacobs2, Robert H Anderson4.   

Abstract

Entities:  

Year:  2021        PMID: 36003420      PMCID: PMC9390137          DOI: 10.1016/j.xjon.2021.09.050

Source DB:  PubMed          Journal:  JTCVS Open        ISSN: 2666-2736


× No keyword cloud information.
To the Editor: Dr Jacobs is a Consultant for SpecialtyCare and the American Academy of Dermatology. All other authors reported no conflicts of interest. The Journal policy requires editors and reviewers to disclose conflicts of interest and to decline handling or reviewing manuscripts for which they may have a conflict of interest. The editors and reviewers of this article have no conflicts of interest. We congratulate the authors of the recently published “International Consensus Statement on Nomenclature and Classification of the Congenital Bicuspid Aortic Valve and Its Aortopathy.” Any evidence-based consensus is to be applauded. The recent “international consensus” regarding the aortic valve is said to be subject to change in accordance with evidence-based data. As is also stated, “nomenclature refers to the choice of 'name' that is given to a particular structure, abnormality or phenotype.” For more than 2 decades, our International Society for Nomenclature of Paediatric and Congenital Heart Disease (https://ipccc.net/) has been seeking to produce such names for the various congenitally malformed hearts, including the bicuspid aortic valve. We also agree that classifications should be based on the English language. In this regard, “cusp” is currently used in a confusing fashion. A “Tower of Babel” was identified with regard to whether the moving parts of the aortic root should be described as “cusps” or “leaflets,” with “leaflet” being preferred. The International Consensus has chosen to use “cusp.” Had this been its only usage, there would have been no problem. In the legend to Figure 11, however, the coronary arteries are initially described as arising from the arterial valvar sinuses but then potentially arising “from each cusp.” “Cusp” is often used indiscriminately to account for both leaflets and sinuses. The better option is to be descriptive, describing leaflets and sinuses, particularly for those aiming surgically to preserve the dysfunctional valve. The interleaflet triangles, given little attention in this consensus, are described as being “inter-cusp.” The extent of their development, or lack thereof, underlies the spectrum of abnormality. Their understanding serves to guide surgical repair. Problems also exist regarding the “annulus.” The consensus, in keeping with the German surgeons, agree this should be represented by the virtual basal ring. It is a mistake, however, to correlate the virtual basal ring of the aortic root with the ventriculo-aortic junction. Such a discrete junction exists only in the sinuses supporting the coronary arteries (Figure 1).,
Figure 1

In the middle panel, the yellow dots mark the virtual basal ring, whereas the red dots mark the anatomic ventriculo-aortic junction with myocardium incorporated into the base of the right and left coronary aortic sinuses. Note the fibrous continuity between the aortic and mitral valves where the muscular support is discontinuous. The green dots mark the outline of the aortic valvar sinuses and mark the hemodynamic ventriculo-aortic ventricular junction. The black dots mark the sinotubular junction. The black line in the middle panel marks the plane of the microscopic section to the left of the middle panel showing the muscular support (red dots) beneath the right coronary leaflet. The blue line marks the plane of section corresponding to the microscopic section in the right-hand panel and demonstrates the fibrous support (double-headed blue arrow) beneath the noncoronary aortic valvar sinus. In both the left and right-hand panels, the yellow arrow marks the virtual basal ring.

In the middle panel, the yellow dots mark the virtual basal ring, whereas the red dots mark the anatomic ventriculo-aortic junction with myocardium incorporated into the base of the right and left coronary aortic sinuses. Note the fibrous continuity between the aortic and mitral valves where the muscular support is discontinuous. The green dots mark the outline of the aortic valvar sinuses and mark the hemodynamic ventriculo-aortic ventricular junction. The black dots mark the sinotubular junction. The black line in the middle panel marks the plane of the microscopic section to the left of the middle panel showing the muscular support (red dots) beneath the right coronary leaflet. The blue line marks the plane of section corresponding to the microscopic section in the right-hand panel and demonstrates the fibrous support (double-headed blue arrow) beneath the noncoronary aortic valvar sinus. In both the left and right-hand panels, the yellow arrow marks the virtual basal ring. Only by using an accurate and descriptive account of the normal anatomy of the aortic root will it be possible to achieve the hoped-for consensus.
  4 in total

Review 1.  The everyday used nomenclature of the aortic root components: the tower of Babel?

Authors:  Hans-Hinrich Sievers; Wolfgang Hemmer; Friedhelm Beyersdorf; Anton Moritz; Rainer Moosdorf; Artur Lichtenberg; Martin Misfeld; Efstratios I Charitos
Journal:  Eur J Cardiothorac Surg       Date:  2011-12-01       Impact factor: 4.191

Review 2.  The Significance of the Interleaflet Triangles in Determining the Morphology of Congenitally Abnormal Aortic Valves: Implications for Noninvasive Imaging and Surgical Management.

Authors:  Justin T Tretter; Diane E Spicer; Shumpei Mori; Sathish Chikkabyrappa; Andrew N Redington; Robert H Anderson
Journal:  J Am Soc Echocardiogr       Date:  2016-10-11       Impact factor: 5.251

3.  Nomenclature for Pediatric and Congenital Cardiac Care: Unification of Clinical and Administrative Nomenclature - The 2021 International Paediatric and Congenital Cardiac Code (IPCCC) and the Eleventh Revision of the International Classification of Diseases (ICD-11).

Authors:  Jeffrey P Jacobs; Rodney C G Franklin; Marie J Béland; Diane E Spicer; Steven D Colan; Henry L Walters; Frédérique Bailliard; Lucile Houyel; James D St Louis; Leo Lopez; Vera D Aiello; J William Gaynor; Otto N Krogmann; Hiromi Kurosawa; Bohdan J Maruszewski; Giovanni Stellin; Paul Morris Weinberg; Marshall Lewis Jacobs; Jeffrey R Boris; Meryl S Cohen; Allen D Everett; Jorge M Giroud; Kristine J Guleserian; Marina L Hughes; Amy L Juraszek; Stephen P Seslar; Charles W Shepard; Shubhika Srivastava; Andrew C Cook; Adrian Crucean; Lazaro E Hernandez; Rohit S Loomba; Lindsay S Rogers; Stephen P Sanders; Jill J Savla; Elif Seda Selamet Tierney; Justin T Tretter; Lianyi Wang; Martin J Elliott; Constantine Mavroudis; Christo I Tchervenkov
Journal:  Cardiol Young       Date:  2021-07       Impact factor: 1.093

Review 4.  Summary: International consensus statement on nomenclature and classification of the congenital bicuspid aortic valve and its aortopathy, for clinical, surgical, interventional, and research purposes.

Authors:  Hector I Michelena; Alessandro Della Corte; Arturo Evangelista; Joseph J Maleszewski; William D Edwards; Mary J Roman; Richard B Devereux; Borja Fernández; Federico M Asch; Alex J Barker; Lilia M Sierra-Galan; Laurent De Kerchove; Susan M Fernandes; Paul W M Fedak; Evaldas Girdauskas; Victoria Delgado; Suhny Abbara; Emmanuel Lansac; Siddharth K Prakash; Malenka M Bissell; Bogdan A Popescu; Michael D Hope; Marta Sitges; Vinod H Thourani; Phillippe Pibarot; Krishnaswamy Chandrasekaran; Patrizio Lancellotti; Michael A Borger; John K Forrest; John Webb; Dianna M Milewicz; Raj Makkar; Martin B Leon; Stephen P Sanders; Michael Markl; Victor A Ferrari; William C Roberts; Jae-Kwan Song; Philipp Blanke; Charles S White; Samuel Siu; Lars G Svensson; Alan C Braverman; Joseph Bavaria; Thoralf M Sundt; Gebrine El Khoury; Ruggero De Paulis; Maurice Enriquez-Sarano; Jeroen J Bax; Catherine M Otto; Hans-Joachim Schäfers
Journal:  J Thorac Cardiovasc Surg       Date:  2021-07-22       Impact factor: 5.209

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.